It is composed of a catalytic subunit responsible for polymerase and exonuclease activity and a small accessory subunit that enhances binding and processivity. 3 Exonuclease activity allows for proofreading of the growing DNA strand and increases faithful copying of mtDNA. 4 Other investigators employed transgenic mouse (TG) models of defective mtDNA replication that expressed exonucleolytic proofreading-deficient Pol g and that yielded increased mtDNA mutations 5 and cardiomyopathy (CM), 6, 7 but oxidative stress was not operative in those studies. 8, 9 Those experimentally constructed, engineered Pol g mutations lacked a pathophysiologically based counterpart in human disease. In contrast, studies here used a TG generated with cardiactargeted human mutant POLG that encodes Y955C Pol g. This mutation causes Chronic Progressive External Ophthalmoplegia (CPEO), an authentic human mitochondrial illness that rarely causes CM. 10 This clinical fact enabled us to use the cardiac targeted Y955C TG in structural and functional evaluations of the target without confounding effects from other tissues. TGs here developed CM, mtDNA depletion, and oxidative stress.
CPEO is an inherited disorder (either autosomal dominant or recessive) with features of mtDNA depletion and accumulation of mtDNA mutations. The illness is characterized by adult onset, bilateral ptosis, progressive weakness of the external ocular muscle, blepharoptosis, ophthalmoparesis, skeletal myopathy with ragged red fibers, wasting, exercise intolerance, and depressed activity of respiratory chain enzymes. 11 Large-scale deletions of mtDNA occurred in muscle biopsies obtained from members of kindreds with autosomal dominant CPEO. 12 This suggested a specific autosomal gene could be responsible for mtDNA instability. Positional cloning linked four genes to the observation that included the adenine nucleotide translocator (ANT1) at locus 4q34-35, 13 mitochondrial helicase (Twinkle) at locus 10q24, 14 thymidine phosphorylase (associated with recessive mitochondrial neurogastrointestinal encephalo-myopathy; [MNGIE] , a form of CPEO) 15 at locus 22q13.32-qter, and the gene encoding the catalytic subunit of Pol g, POLG, at locus 15q25. 16 One recently reported patient with autosomal dominant CPEO harbored a mutation in the gene for the Pol g accessory subunit. 17 Importantly, candidate genes encode products that replicate mtDNA 2 or are involved with metabolism of nucleotide precursors for mtDNA replication.
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Y955C is the most common and severe autosomal dominant mutation in the POLG gene. 16, 19 It is associated with CPEO and Parkinsonism 20 and recently described to cause premature ovarian failure. 21 Tyr955 interacts with the incoming dNTP in the active site within the polymerase domain to maintain high fidelity of DNA synthesis. 22 Recombinant Y955C Pol g exhibits o1% wild-type (WT) activity and severely decreased processivity. This stalling of mtDNA synthesis with minimal catalytic activity may explain the profound clinical changes in Y955C heterozygotes, 23 but has not been defined pathophysiologically in a murine transgenic model. Substitution of Y955 to cysteine also increases nucleotide misinsertion errors 1-2 orders of magnitude in absence of exonucleolytic proofreading. 22 Of note, other POLG point mutations are associated with CM, 24 albeit uncommonly.
We published biochemical data on the mutant Y955C Pol g protein in CPEO, 2, 22, 23, 25 however the Y955C POLG mutation has not been investigated in transgenic murine models. The effect of human Y955C Pol g on the murine heart was explored using transgenically targeted Y955C POLG driven by the alpha myosin heavy chain promoter (aMyHC). This transgenic approach was pioneered by Robbins, 26 and was adapted and used successfully by us in the past 22, [27] [28] [29] and in studies here. Cardiac targeted Y955C POLG yielded expression of abundant but enzymatically defective Pol g polypeptide in TG hearts. This resulted in inefficient mtDNA replication, mitochondrial oxidative stress, and structural and functional features of CM. TG experiments demonstrated that inefficient mtDNA replication and mitochondrial oxidative stress are bona fide contributors to CM and that mtDNA depletion results from a Pol g mutation.
MATERIALS AND METHODS
Generation of a-MyHC/Y955C Transgenic Mice (TG) Established methods and approaches with the a-MyHC 30 were applied to the Y955C Pol g TG in ways that resembled those used previously. 27 ,29,31,32
Genotyping
For the TG line a-MyHC/Y955C, the presence of the mutant transgene was detected in the founders and their offspring using Southern blotting and real-time PCR essentially as recently described. 27, 29, 32 TG Gene Copy Analysis Four transgenic lines were established for the targeted overexpression of mutant POLG. To determine the relative copy number in each, the level of human Y955C POLG was analyzed semiquantitatively from tail DNA extracts using realtime PCR and Light Cycler TaqMan Master kit. Target genes were amplified using specific primers for human POLG 
SDS PAGE Coomassie Blue Staining and Western Blotting
To quantitate protein abundance in the mitochondrial lysate, proteins were resolved on SDS PAGE in Criterion 4-12% BisTris gels followed by Coomassie Blue staining. To quantitate Pol g, a similar gel (five-fold overload of mitochondrial lysate) was prepared and transferred to Imobilon-P for Western blotting using anti-human Pol g antibody (DPg) as described. 33 Mortality of Y955C Pol c TG Lines Kaplan-Meier survival curves were generated and calculated according to standard methods on all TG lines and on WT littermates (pooled; N ¼ 16). mtDNA and Nuclear DNA (nDNA) Quantitation in Heart Tissue from Y955C Pol c TGs Using Real-Time PCR Methods employed were based on modifications of those used by others 34, 35 and detailed by us recently. 32 Briefly, DNA sequences for primers and probes used for quantization of mitochondrial and nuclear DNA with real-time PCR technique were adapted from others. 25 The accessory subunit of murine mitochondrial DNA polymerase gamma (ASPG) and mouse mitochondrial cytochrome oxidase subunit 1 (COX) were the subjects of separate quantization of mouse nuclear and mitochondrial DNA, respectively. The mitochondrial forward primer (5 0 -TCGTTGATTATTCTCAACCAATCA-3 0 ) and reverse primer (5 0 -GCCTCCAATTATTATTGGTATTAC TATGA-3 0 ) were used to amplify the target segment of COXI gene. Hybridization probes were 3 0 -flouresceine 0 ) oligonucleotide were used as hybridization probes for the nuclear gene. Amplification was performed in a LightCycler 480 (Roche) and consisted of a denaturation step (8 min), 50 cycles of amplification (951C for 8 s, 551C for 10 s followed by single fluorescence acquisition, and 721C for 10 s), a melting curve (951C for 30 s with a ramping rate of 4.81C/s, 451C for 61 s with a ramping rate of 2.51C/s and 951C for 0 s), and a cooling cycle (401C). Temperature ramping rates were 2.51C/s unless noted.
Standard DNA curves for quantization of the LC products were employed. Both mitochondrial and nuclear target sequences were PCR amplified and cloned into the pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol. Each plasmid was linearized by digestion with HindIII restriction dendonuclease (Roche) following the manufacturer's protocol. Each fragment insert was then PCR amplified using their corresponding original primers and ran out on 2% agarose gels to ensure quality and proper size of the inserts.
Analysis of mtDNA for 8-hydroxy-2-deoxyguanosine (8-OHdG) as a Marker of Mitochondrial Oxidative Stress Mitochondrial DNA from TG (C line) and WT myocardium was hydrolyzed to nucleosides using nuclease P1 and alkaline phosphatase as described previously. 36 Cardiac mtDNA samples were isolated (mtDNA Extractor CT Kit, Wako Chemicals USA, Inc., Richmond, VA, USA), and analyzed for abundance of 8-OHdG (as a marker for oxidative stress to mtDNA 37, 38 ) relative to abundance of 2-deoxyguanosine (2dG; Â 10
À5
) by HPLC coupled with coulometric electrochemical and spectrophotometric detection (CoulArray Model 5600; ESA Inc., Chelmford, MA, USA). Nucleoside concentrations were calculated from multipoint standard curves generated daily with freshly prepared standards at concentrations that encompassed those observed in the samples. 8-OHdG levels were expressed as a mean molar ratio and standard error of the mean (s.e.m.) to 10 À5 2dG (N ¼ 6).
Echocardiography in Y955C Pol c TGs and WT Echocardiography was performed on age-and gender-matched WT and TGs as described previously. 39 For ECHO ob-
MRI of the Heart in Y955C Pol c TGs and WT Littermates Y955C Pol g line D TG (n ¼ 3) and WT littermates (n ¼ 3) were evaluated via MRI at 16-20 weeks as has been recently described. 32 MRI was accomplished on a 4.7T Varian/INOVA (200/33) Spectroscopy and Imaging System (Varian, Palo Alto, CA, USA).
Histopathological Features from Y955C TG Hearts
Hearts from Y955C (C line, n ¼ 3 per cohort; 60 days old) and equal numbers of WT littermates were rapidly removed, immersion fixed in 10% neutral-buffered formalin at ambient temperature for 24 h, and carefully bi-valved to demonstrate views of the ventricular chambers and to document cardiomegaly, or cytological changes such as hypertrophy. Samples were processed, sectioned (6 mm), stained individually with hematoxylin and eosin or with Masson's Trichrome and examined microscopically on a Nikon 800 Ultraphot Microscope (Nikon, Melville, NY, USA). All images were saved electronically to enable histopathological changes in hearts of TGs to be compared to those of WTs.
Ultrastructural Pathological Evaluations (EM) of Cardiac Mitochondria in Y955C POLG TGs
Samples from TG (C line) and WT murine hearts (N ¼ 12) were evaluated using EM to define mitochondrial structural changes. Sections (approximately 1 mm cubes) were rapidly fixed in diluted Karnovsky's fixative and processed for EM as in the past. 39 Embedded sections (0.5 mm) were cut with a glass knife and stained with Toluidine Blue for orientation. Ultrathin (900 Å ) sections were cut with a diamond knife, stained with uranyl acetate and lead citrate and viewed on a Philips Morgagni electron microscope (Philips, Amsterdam, NL, USA). Each EM image was reviewed independently by two investigators for the presence of mitochondrial proliferation or structurally abnormal mitochondria (eg, intramitochondrial lamellar bodies, cristae reduplication). 40 Structurally damaged mitochondria were operationally defined as having loss or dissolution of Z25% of cristae along with the above features.
Statistical Analysis
For mtDNA quantitation, data were expressed as the ratio of mean value of the mtDNA measurement to the mean value of nDNA divided by 1000 and the resultant values are expressed as mean7standard error. A value of Po0.05 (determined by Student's unpaired t-test) was considered statistically significant. Echocardiographic determinations from all groups were compared by ANOVA. 39 
RESULTS

Polypeptide Blotting of Pol c in Cardiac Mitochondrial Extracts
Mitochondria isolated from Y955C TG and WT mouse hearts were assayed for relative abundance of human Y955C Pol g polypeptide. Western blots containing equal amounts of Transgenic CPEO, mtDNA, and oxidative stress W Lewis et al cardiac mitochondrial protein were probed with the DPg polyclonal antibody (Figure 1a ), which crossreacted with mouse Pol g (data not shown). Western blot analyses of mitochondrial extracts from both TG and WT hearts revealed that Y955C TG heart samples (lanes 2, 4, and 6) displayed increased signal density of the Pol g band (140 kDa). The bands from TG heart samples comigrated with the authentic Pol g control (lane 1, Figure 1a) . In contrast, Pol g was not seen in extracts of mitochondria from WT hearts, indicating that the native murine Pol g polypeptide was below the threshold of detection. Figure 1b demonstrates equivalent protein amounts were loaded. Protein from purified mitochondrial lysates of TG and control hearts were separated on a 4-12% polyacrylamide gel and either transferred to Immobilon-P for Western blot analysis or Coomassie Blue staining. (a) Western blot analysis of the heart mitochondrial extracts. Lane 1, purified recombinant human Pol g as control; lanes 2, 4, and 6, mitochondrial lysates from Y955C TG hearts of 33-, 25-, and 10-week-old mice, respectively. Lanes 3, 5, and 7, mitochondrial lysates from control TG-negative hearts of 33-, 25-, and 10-week-old mice, respectively. Arrow indicates pol g. (b) Coomassie Bluestained gel to demonstrate that equivalent portions of heart mitochondrial proteins were analyzed by Western blot. Lanes 1-7 are identical to that in (a) except that five times the amount of protein was loaded and separated in the gel for detection by Coomassie Blue staining. (c) Relative gene copy number of mutant Y955C Pol g was determined from cardiac tissues for each of the four lines generated. Arrow indicates pol g. (c) Relative gene copy number of human mutant Y955C Pol g was determined from cardiac tissues for each of the four lines generated. Levels of POLG were analyzed semiquantitatively from murine tail DNA extracts using real-time PCR and Light Cycler TaqMan Master kit and normalized to GAPDH from WT. Transgenic CPEO, mtDNA, and oxidative stress W Lewis et al lateral atrial enlargement, consistent with congestive heart failure ( Figure 2b ).
mtDNA Copy Number
Depletion of mtDNA is one hallmark of mtDNA dysfunction, and of CPEO. The accessory subunit of murine mitochondrial DNA polymerase gamma (ASPG) and mouse mitochondrial 17kDa subunit of COX 1 were the subjects of separate quantization of mouse nuclear and mitochondrial DNA, respectively (Figure 3a) . In both young and older cohorts, Y955C TG mice exhibited reduced mtDNA abundance consistently (mtDNA/nDNC ratio) compared to their respective WT cohorts. These suggest Y955C transgene expression causes substantial mtDNA depletion in the heart and could account for CM, CHF and increased mortality.
8-OHdG in Mitochondria from Y955C TG Hearts
Mitochondria from Y955C heart samples were assessed for oxidative stress by isolating them from heart tissue (to remove nuclear DNA) followed by analyzing abundance of 8-OHdG in comparison to 2dG Â 10
À5
. 8-OHdG levels in mtDNA from mitochondria of Y955C hearts were elevated three-fold over those found in WT control hearts (Po0.05; Figure 3b) , consistent with our studies on other murine models of mitochondrial oxidative stress. 32 Figure 5 is a representative four-chamber view from a gender-matched TG and WT littermates at 16 weeks of age. The image from the Y955C TG heart reveals cardiomegaly, biventricular dilation, and atrial enlargement compared to similar MRI views of hearts of WT littermates. This corroborates echocardiographic findings and confirms CM.
Photomicrographs of Y955C TG Hearts and WTs
To identify cardiac structural changes at the microscopic level in TGs, whole mount photomicrographs and high-power light photomicrographs were taken of TGs and WT littermates (Figure 6a and b) . Cardiomegaly was observed in TGs with increased cavity dimensions of LV and RV, and free wall and septal thickening in TGs. These findings corroborated observations from both ECHO and MRI studies above that indicated CM. Histopathological examination revealed myocytolysis and cardiomyocyte hypertrophy, with multiple cytoplasmic granular figures that were consistent with mitochondria. Together, these histopathological features support the CM diagnosis.
Ultrastructural Features of Mitochondria in TG Hearts
EM photomicrographs of Y955C Pol g TG hearts reinforced histopathological data and correlated with changes in mtDNA. Findings of mitochondrial cristae dissolution and . Steady-state abundance of 8-OHdG in Y955C hearts was threefold to that found in WT (Po0.05) (N ¼ 6).
Transgenic CPEO, mtDNA, and oxidative stress W Lewis et al swelling and conspicuous defects in matrix density were commonly seen in Y955C Pol g TG hearts compared to the age-and gender-matched WT controls (Figure 6c ).
DISCUSSION
Pol g is responsible for replication of mtDNA. 2 Mutations in POLG, the gene for the catalytic subunit, cause CPEO, Alper's syndrome, ataxia-neuropathy, Parkinsonism, 2,42 and other heritable conditions. 24 Targeted cardiac TGs were used to define features of cardiac dysfunction and CM, 26 and were applied to explore features of CM in AIDS 43 where nucleoside reverse transcriptase inhibitors (NRTIs) cause mitochondrial dysfunction in the heart. 44 Transgenic targeting of human Pol g harboring the Y955C pathogenic mutation here resulted in depleted mtDNA, oxidative stress, pathological cardiomegaly, cardiac mitochondrial ultrastructural damage, CM with LV dysfunction, bradycardia, and premature death. These findings forge a pathogenetic link between defective mtDNA replication and cardiac dysfunction with overwhelming depletion of mtDNA and mutant human Pol g expressed in the murine heart. TG experiments here causally linked transgenically targeted cardiac expression of Y955C Pol g enzyme (derived from a known pathogenic mutation in POLG) to mtDNA depletion, oxidative stress, and dysfunction (in the form of CM). In the targeted TG, it is reasonable that Y955C Pol g affected mtDNA replication at the level of enzyme:template interface by reducing relative availability of native Pol g compared to the mutant. The Y955C mutant polypeptide was sufficiently abundant in this model to disrupt mtDNA homeostasis by overwhelming native Pol g and becoming the dominant enzyme in the system but with substantially di- Figure 4 Quantitative analysis of ECHO images in Y955C Pol g TG: LV mass was calculated in a blinded fashion, code was broken, and data were tabulated from the Y955C Pol g TG lines at 120 days. Data were normalized to body weight (mg/g) and plotted as mean7s.e.m. At 120 days, line C and D had survivors. They exhibited cardiac mass that was 4100% increased above that of WT (*Po0.01).
TG Y955C
WT Figure 5 MRI of TG and WT hearts: MRI images of the murine heart were performed using methods as described previously. Four-chamber enlargement in TG Y955C (left) and WT littermate (right) at 9 months of age. TG demonstrates four-chamber enlargement of the heart with both right ventricle (open arrow) and left ventricle (filled arrow) enlargement.
Transgenic CPEO, mtDNA, and oxidative stress W Lewis et al minished enzyme activity. The subcellular outcome was mitochondrial oxidative stress documented by increased abundance of 8-OHdG.
Homeostasis of the mtDNA replicative machinery is regulated. 18 In the present model, genetic disruption with expression of this mutant Pol g resulted in organ dysfunction Figure 6 Histopathological (a, b) and EM (c) images of hearts and of mitochondria from Y955C Pol g TGs: gender-matched littermates expressing Y955C TG or WT controls were used. TG overexpression in the heart caused CM with biventricular thickening and cardiomegaly. Arrow points to lytic change with increased granularity (Y955C: a, original magnification Â 1, and b, original magnification Â 600). Histopathological results (hematoxylin and eosin staining) were supported by mitochondrial damage and enlargement as seen by EM (c, original magnification on EM: 26 000. Marker is 1 mm).
Transgenic CPEO, mtDNA, and oxidative stress W Lewis et al and premature death (Figure 7 ). Based on mass action of the mutant Y955C Pol g, a 'dominant negative' phenotype was the first step in organellar dysfunction and ultimately cardiac dysfunction. It also may be inferred that, at least at the level of mtDNA replication machinery in the mouse, human Y955C mutant Pol g may substitute effectively for native murine Pol g or interfere with the murine mtDNA replicon. Transgenic substitution here allows mutant human Pol g to participate directly in mtDNA replication with resultant depletion. Data here do not directly explain the organ-specific nature of mtDNA defects in CPEO. However, they can apply to and reinforce the 'OXPHOS paradigm' of Wallace in which organs that require significant energy from oxidative phosphorylation may be principal targets for genetic mitochondria diseases in which oxidative phosphorylation is limited. 45 The present work extends previous studies that focused on disruption of mtDNA biogenesis at the level of the mitochondrial nucleotide pools. In those studies, TGs were treated with NRTIs that compete with native nucleotides for intramitochondrial phosphorylation and transport. 31, 32, 39, 46, 47 Data indicated transport of nucleotides into mitochondria may be disrupted by NRTIs.
Genetic 'mtDNA depletion syndromes' 48, 49 offer support for the reasoning used in generating these experimental models and for the data obtained from them. In those illnesses, mitochondrial and cytoplasmic nucleotide pools are disturbed by mutations of kinases, transporters, and enzymes involved in nucleotide pool homeostasis. Such mutations yield mtDNA depletion. 'Acquired mtDNA depletion' from administration of NRTIs for AIDS 31, 32 offers a pharmacological model to deplete mtDNA in vivo. NRTI chemical structure, dose, and duration of therapy each impacted the extent of mtDNA depletion and tissue target. 31, 32 This TG model strengthens the pathogenetic link between defects in mtDNA replication and cardiac dysfunction, particularly CM. 50 Although not proven here (owing to the severity of the TG phenotype), it is conceivable that subtle genetic mutations in Pol g (already described or yet to be uncovered) may offer further mechanistic insights if examined transgenically. Presently, there are over 70 documented disease mutations and a handful of singlenucleotide polymorphisms in the POLG gene (http:// dir-apps.niehs.nih.gov/polg/index). Such Pol g mutations may exhibit only mild enzyme dysfunction without a phenotype in the native, undisturbed condition. However, a mitochondrial dysfunction phenotype could occur in selected tissues if a challenge with NRTIs that deplete mtDNA 32 and cause oxidative stress 36 were added. If these events (mutation of polymerase and disturbed nucleotide pools from NRTIs) were to coincide, significant side effects could result. The combination of genetic predisposition and environmental effects serves as a cornerstone of the threshold effect seen in mitochondrial genetic diseases and related systems, as articulated by Wallace and co-workers. 45, 51 In summary, this study utilized TGs that expressed human Y955C Pol g in the murine heart to define defective mtDNA replication in vivo at the level of the enzyme machinery that replicates mtDNA. Targeted cardiac transgenic expression of Y955C Pol g was sufficient to yield a molecular phenotype of mtDNA depletion, a biochemical phenotype with increased abundance of the mutant enzyme in the target, increased 8-OHdG, histopathological and mitochondrial ultrastructural changes in cardiac cells of TGs, and organ dysfunction with cardiomegaly, increased ventricular volume, increased cardiac mass on ECHO and MRI. Together, these interrelated findings underscore mtDNA replication as the nexus for dysfunction. It is reasonable to suggest that when a threshold of genetic mtDNA replication defects occurs, particularly from ineffective Pol g function, cardiac dysfunction and pathological features of CM is an outcome. The role of defective mtDNA replication in various CMs merits deeper investigation in the future. 
